Bank of America’s NxStage Medical Inc. NXTM Stock Holding History

Bank of America’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-50,000	Closed	-$1.1M	–	7532
2015 Q4	$1.1M	Buy	+50,000	New	+$932K	﹤0.01%	4299
2015 Q3	–	Sell	-26,000	Closed	-$371K	–	7563
2015 Q2	$371K	Buy	+26,000	New	+$440K	﹤0.01%	4911
2014 Q4	–	Sell	-95,000	Closed	-$1.25M	–	8148
2014 Q3	$1.25M	Buy	+95,000	New	+$1.28M	﹤0.01%	3803

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Bank of America's NXTM Position: Q1 2019 in Review

Bank of America sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 58,381 shares — an estimated $1.67M sold.

Bank of America first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $5.67M in Q1 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Bank of America reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Bank of America sold 58,381 NxStage Medical Inc. shares in Q1 2019, an estimated $1.67M.
Bank of America first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
Bank of America's NxStage Medical Inc. position peaked at $5.67M in Q1 2017.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Bank of America's 13F filing for Q1 2019, filed 15 May 2019.